⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Xavo and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Xavo
↗Bayreuth, Germany (Global); Boston, MA, USA (US Operations)
Xavo is a specialized software provider focused on the biopharma and life sciences R&D sector. The company develops AI-assisted Software-as-a-Service (SaaS) platforms designed to optimize laboratory operations, sample management, and workflow orchestration. By connecting research informatics with physical lab automation, Xavo aims to bridge the gap between early-stage experimentation and large-scale production.
In late 2025, Xavo significantly expanded its capabilities by acquiring Laboperator from Labforward GmbH. This strategic move integrated advanced laboratory automation, instrument connectivity, and GxP-compliant workflow management into Xavo's existing digital ecosystem, positioning the company as a provider of end-to-end digital laboratory execution solutions.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Laboratory Informatics & Automation
SIZE & FINANCIALS
Employees:51-200
Founded:2000
Ownership:private
Status:operating
FUNDING
Stage:Unfunded
Total Raised:$0
0
CORPORATE STRUCTURE
Subsidiaries:Laboperator GmbH
Key Partnerships:Scigilian (Discovery Platform integration), Workflow Informatics (Integration and customization services)
COMPETITION
Position:Challenger
Competitors:Zephyr AI, Chemify, RevolKa, Scispot
LEADERSHIP
Key Executives:
Andreas Suchanek - CEO & President
Florian Tauchert - Co-founder & Managing Director
LINKS
Website:xavo.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Xavo. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.